OOIR: Observatory of International Research

Papers

(The TQCC of Critical Reviews in Microbiology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases	160
Dynamics of antibiotic resistance genes in plasmids and bacteriophages	83
TREM-2: friend or foe in infectious diseases?	75
Helicobacter pylori infection: from standard to alternative treatment strategies	66
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids	59
Salmonella in eggs and egg-laying chickens: pathways to effective control	55
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19	49
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies	43
Paving the way forward: Escherichia coli bacteriophages in a One Health approach	42
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases	41
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens	41
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication	39
Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions	37
Biosynthesis, regulation, and biological significance of fumonisins in fungi: current status and prospects	36
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings	34
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections	33
Bile acid–gut microbiota crosstalk in irritable bowel syndrome	31
LysR-type transcriptional regulators: state of the art	30
Applications of bacteriophages against intracellular bacteria	29
Exploring halophilic environments as a source of new antibiotics	28
Vibrio cholerae virulence and its suppression through the quorum-sensing system	27
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review	26
The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma	26
The microbiome and precision oncology: an emerging paradigm in anticancer therapy	25
Biofilm formation in clinically relevant filamentous fungi: a therapeutic challenge	25

Emerging cellular and molecular interactions between the lung microbiota and lung diseases	25
Advances in the applications of Bacteriophages and phage products against food-contaminating bacteria	24
The role of influenza A virus-induced hypercytokinemia	24
Building up a clinical microbiota profiling: a quality framework proposal	23
The diffusible signaling factor family in microbial signaling: a current perspective	23
Bacterial vaginosis: advancing insights into microbial dysbiosis	22
The role of single and mixed biofilms in Clostridioides difficile infection and strategies for prevention and inhibition	22
Polyamine as a microenvironment factor in resistance to antibiotics	22
Endophytic fungi-bioinspired nanoparticles potential to control infectious disease	22
Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness	21
Emergence of persister cells in Staphylococcus aureus : calculated or fortuitous move?	20
Phage-bacterial evolutionary interactions: experimental models and complications	19
Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections	18
Burkholderia in the genomic era: from taxonomy to the discovery of new antimicrobial secondary metabolites	18
Microbial persisters and host: recent advances and future perspectives	18
Biotherapeutic potential of gut microbiota-derived indole-3-acetic acid	18
Antibiotic resistance in Pseudomonas aeruginosa : mechanisms and emerging treatment	17
Ureaplasma infections: update on epidemiology, antimicrobial resistance, and pathogenesis	17
Advances in mining and expressing microbial biosynthetic gene clusters	16
Microbial biosynthesis of nucleos(t)ide analogs: applications, and engineering optimization	16
Bacillusspore-forming probiotics: benefits with concerns?	16
Ocular surface microbiota dysbiosis contributes to the high prevalence of dry eye disease in diabetic patients	15
Quorum sensing in biofilms: a key mechanism to target in ecotoxicological studies	15
Porphyromonas gingivalis and the pathogenesis of Alzheimer’s disease	14
Review on computer-assisted biosynthetic capacities elucidation to assess metabolic interactions and communication within microbial communities	14
Current types of staphylococcal cassette chromosome mec (SCC mec ) in clinically relevant coagulase-negative staphylococcal (CoNS) species	14
Insights into the molecular basis of c-di-GMP signalling in Pseudomonas aeruginosa	13
Aspergilli series Versicolores: importance of species identification in the clinical setting	13
The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential	13